Synthesis and studying the antitumor activity of novel 5-(2-methylbenzimidazol-5-yl)-1,3,4-oxadiazole-2(3H)-thiones
暂无分享,去创建一个
[1] F. Ragab,et al. Novel benzimidazole-pyrimidine conjugates as potent antitumor agents. , 2010, European journal of medicinal chemistry.
[2] K. Shah,et al. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents. , 2009, Bioorganic & medicinal chemistry letters.
[3] Sean M Kerwin,et al. New transition metal ion complexes with benzimidazole-5-carboxylic acid hydrazides with antitumor activity. , 2009, European journal of medicinal chemistry.
[4] L. Karlsson,et al. 2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2. , 2007, Bioorganic & medicinal chemistry letters.
[5] H. Tokuda,et al. Synthesis and inhibitory activity of new benzimidazole derivatives against Burkitt's lymphoma promotion. , 2007, Bioorganic & medicinal chemistry.
[6] M. Gottardis,et al. Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile. , 2007, Bioorganic & medicinal chemistry letters.
[7] Mohamed A. Omar,et al. Synthesis and antitumor activity of 1-substituted-2-methyl-5-nitrobenzimidazoles. , 2006, Bioorganic & medicinal chemistry.
[8] H. Abdel-Rahman,et al. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents. , 2006, Bioorganic & medicinal chemistry.
[9] Cristiano Ruch Werneck Guimarães,et al. Elucidation of fatty acid amide hydrolase inhibition by potent alpha-ketoheterocycle derivatives from Monte Carlo simulations. , 2005, Journal of the American Chemical Society.
[10] Mercedes González,et al. Imidazole and benzimidazole derivatives as chemotherapeutic agents. , 2005, Mini reviews in medicinal chemistry.
[11] L. Karlsson,et al. Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. , 2005, Journal of medicinal chemistry.
[12] J. Bain,et al. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. , 2004, Journal of medicinal chemistry.
[13] L. Pinna,et al. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2. , 2004, Biochemical and biophysical research communications.
[14] M. Shalaby,et al. Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents. , 2003, European journal of medicinal chemistry.
[15] F. Chau,et al. Synthesis and evaluation of 5-Aryl-3-(4-hydroxyphenyl)-1,3,4-oxadiazole-2-(3H)-thiones as P-glycoprotein inhibitors. , 2003, Chemical & pharmaceutical bulletin.
[16] S. Kerwin,et al. Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1. , 2002, Bioorganic & medicinal chemistry.
[17] Y. Imaeda,et al. Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo. , 2002, Cancer letters.
[18] Jean M. Severin,et al. Identification of novel inhibitors of urokinase via NMR-based screening. , 2000, Journal of medicinal chemistry.
[19] O. Aboulwafa,et al. Synthesis of some substituted benzimidazoles with potential antimicrobial activity , 1989 .
[20] Donald J. Soisson,et al. The Preparation of 3-Methyl-6- and -7-carboxy-2-quinoxalones , 1961 .